###begin article-title 0
###xml 85 90 <span type="species:ncbi:9606">Human</span>
PI-3K/Akt Pathway-Dependent Cyclin D1 Expression Is Responsible for Arsenite-Induced Human Keratinocyte Transformation
###end article-title 0
###begin p 1
These authors contributed equally to the work.
###end p 1
###begin p 2
The authors declare they have no competing financial interests.
###end p 2
###begin title 3
Background
###end title 3
###begin p 4
###xml 40 45 <span type="species:ncbi:9606">human</span>
###xml 109 114 <span type="species:ncbi:9606">human</span>
Long-term exposure of arsenite leads to human skin cancer. However, the exact mechanisms of arsenite-induced human skin carcinogenesis remain to be defined.
###end p 4
###begin title 5
Objectives
###end title 5
###begin p 6
###xml 97 102 <span type="species:ncbi:9606">human</span>
In this study, we investigated the potential role of PI-3K/Akt/cyclin D1in the transformation of human keratinocytic cells upon arsenite exposure.
###end p 6
###begin title 7
Methods
###end title 7
###begin p 8
###xml 102 111 <span type="species:ncbi:10090">nude mice</span>
We used the soft agar assay to evaluate the cell transformation activity of arsenite exposure and the nude mice xenograft model to determine the tumorigenesis of arsenite-induced transformed cells. We used the dominant negative mutant and gene knockdown approaches to elucidate the signaling pathway involved in this process.
###end p 8
###begin title 9
Results
###end title 9
###begin p 10
###xml 229 238 <span type="species:ncbi:10090">nude mice</span>
Our results showed that repeated long-term exposure of HaCat cells to arsenite caused cell transformation, as indicated by anchorage-independent growth in soft agar. The tumorigenicity of these transformed cells was confirmed in nude mice. Treatment of cells with arsenite also induced significant activation of PI-3K and Akt, which was responsible for the anchorage-independent cell growth induced by arsenite exposure. Furthermore, our data also indicated that cyclin D1 is an important downstream molecule involved in PI-3K/Akt-mediated cell transformation upon arsenite exposure based on the facts that inhibition of cyclin D1 expression by dominant negative mutants of PI-3K, and Akt, or the knockdown of the cyclin D1 expression by its specific siRNA in the HaCat cells resulted in impairing of anchorage-independent growth of HaCat cells induced by arsenite.
###end p 10
###begin title 11
Conclusion
###end title 11
###begin p 12
###xml 122 127 <span type="species:ncbi:9606">human</span>
Our results demonstrate that PI-3K/Akt-mediated cyclin D1 expression is at least one key event implicated in the arsenite human skin carcinogenic effect.
###end p 12
###begin p 13
###xml 153 172 153 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9-ehp0116-000001">Centeno et al. 2002</xref>
###xml 174 191 174 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19-ehp0116-000001">Huang et al. 2004</xref>
###xml 193 210 193 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b50-ehp0116-000001">Tseng et al. 1968</xref>
###xml 212 226 212 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b56-ehp0116-000001">Yu et al. 2006</xref>
###xml 352 371 352 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9-ehp0116-000001">Centeno et al. 2002</xref>
###xml 373 387 373 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b56-ehp0116-000001">Yu et al. 2006</xref>
###xml 471 478 471 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 544 561 544 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b50-ehp0116-000001">Tseng et al. 1968</xref>
###xml 563 577 563 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b56-ehp0116-000001">Yu et al. 2006</xref>
###xml 30 35 <span type="species:ncbi:9606">human</span>
Arsenite is a well-documented human carcinogen. Long-term exposure to inorganic arsenic from drinking water has been reported to induce various cancers (Centeno et al. 2002; Huang et al. 2004; Tseng et al. 1968; Yu et al. 2006). Chronic exposure to arsenite can lead to its accumulation in the skin and cause skin hyperpigmentation and hyperkeratosis (Centeno et al. 2002; Yu et al. 2006). This could in turn develop into skin cancers, including Bowen disease (carcinoma in situ), basal cell carcinoma (BCC), and squamous cell carcinoma (SCC) (Tseng et al. 1968; Yu et al. 2006).
###end p 13
###begin p 14
###xml 88 99 88 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18-ehp0116-000001">Hecker 1987</xref>
###xml 101 124 101 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b57-ehp0116-000001">Zoumpourlis et al. 2003</xref>
###xml 746 770 746 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6-ehp0116-000001">Bernstam and Nriagu 2000</xref>
###xml 1052 1070 1048 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12-ehp0116-000001">Cooper et al. 2004</xref>
###xml 1072 1089 1068 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20-ehp0116-000001">Huang et al. 2001</xref>
###xml 1091 1095 1087 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19-ehp0116-000001">2004</xref>
###xml 1285 1297 1281 1293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8-ehp0116-000001">Cantley 2002</xref>
###xml 1299 1323 1295 1319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b51-ehp0116-000001">Vivanco and Sawyers 2002</xref>
###xml 1489 1507 1485 1503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1-ehp0116-000001">Alessi et al. 1997</xref>
###xml 1509 1531 1505 1527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b49-ehp0116-000001">Toker and Cantley 1997</xref>
###xml 1620 1638 1616 1634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1-ehp0116-000001">Alessi et al. 1997</xref>
###xml 1640 1658 1636 1654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14-ehp0116-000001">Franke et al. 2003</xref>
###xml 1835 1852 1831 1848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21-ehp0116-000001">Huang et al. 1999</xref>
###xml 1854 1868 1850 1864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28-ehp0116-000001">Li et al. 2005</xref>
###xml 1870 1897 1866 1893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32-ehp0116-000001">Nicholson and Anderson 2002</xref>
###xml 1899 1918 1895 1914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35-ehp0116-000001">Ouyang et al. 2005a</xref>
###xml 1920 1944 1916 1940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b43-ehp0116-000001">Samuels and Ericson 2006</xref>
###xml 2041 2060 2037 2056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3-ehp0116-000001">Asanuma et al. 2005</xref>
###xml 2062 2077 2058 2073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4-ehp0116-000001">Bae et al. 2006</xref>
###xml 2079 2096 2075 2092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30-ehp0116-000001">Misra et al. 2006</xref>
###xml 2114 2130 2110 2126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17-ehp0116-000001">He et al. (2006)</xref>
###xml 2309 2328 2305 2324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b47-ehp0116-000001">Souza et al. (2001)</xref>
###xml 2630 2648 2626 2644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34-ehp0116-000001">Ouyang et al. 2006</xref>
###xml 2757 2776 2753 2772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36-ehp0116-000001">Ouyang et al. 2007b</xref>
###xml 2865 2881 2861 2877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10-ehp0116-000001">Chen et al. 2001</xref>
###xml 3094 3111 3090 3107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22-ehp0116-000001">Huang et al. 1996</xref>
###xml 2247 2252 <span type="species:ncbi:9606">human</span>
###xml 2444 2449 <span type="species:ncbi:9606">human</span>
###xml 2602 2607 <span type="species:ncbi:10090">mouse</span>
Cancer development results from a synergism between genotoxic and nongenotoxic factors (Hecker 1987; Zoumpourlis et al. 2003). The former induces irreversible genetic alterations (tumor initiation), whereas the latter promotes tumor development by favoring the clone outgrowth of the genetically altered cells (tumor promotion) through activating cell survival and proliferation signal pathways and altering the machineries controlling cell proliferation and apoptosis. Previous studies have demonstrated that arsenite has a weak mutagen effect; therefore it is thought that its ability to activate signaling pathways leading to the alteration of gene expression responsible for cell growth may play an important role in its carcinogenic effect (Bernstam and Nriagu 2000). It has been demonstrated that signal pathways, including mitogen-activated protein kinases (MAPKs), activating factor 1 (AP-1) and nuclear factor kappa B (NF-kappaB), can be activated upon arsenite exposure and presumably contribute to arsenite-induced skin carcinogenic effect (Cooper et al. 2004; Huang et al. 2001, 2004). Phosphatidylinositol 3-kinase (PI-3K) comprises an 85-kDa regulatory subunit (p85) and a 110-kDa catalytic subunit (p110) and could be activated by multiple growth factors and cytokines (Cantley 2002; Vivanco and Sawyers 2002). Upon activation, PI-3K generates phosphatidylinositol-3,4,5-trisphosphate (PIP3), a lipid second messenger essential for the activation of protein kinase B (Akt) (Alessi et al. 1997; Toker and Cantley 1997). Akt in turn regulates various cellular functions such as apoptosis and proliferation (Alessi et al. 1997; Franke et al. 2003). PI-3K/Akt has been demonstrated to be an important signaling pathway for cell survival and growth, and it also plays a pivotal role in cell transformation and tumorigenesis (Huang et al. 1999; Li et al. 2005; Nicholson and Anderson 2002; Ouyang et al. 2005a; Samuels and Ericson 2006). The elevated expression or high phosphorylation of Akt could be observed in many tumor cells (Asanuma et al. 2005; Bae et al. 2006; Misra et al. 2006). Most recently, He et al. (2006) reported that PI-3K/Akt is related to the malignant transformation associated with acquired apoptotic resistance in human HaCaT keratinocytes induced by chronic UVA irradiation. Souza et al. (2001) have reported that PI-3K is required for the induction of endothelial nitric oxide synthesis (eNOS) by arsenite in human keratinocytes. Our previous studies have also shown that arsenite exposure is able to activate the PI-3K/Akt pathway and induce cyclin D1 expression in mouse epidermal Cl41 cells (Ouyang et al. 2006). In HaCat cells, the PI-3K/Akt/cyclin D1 cascade activation contributed to arsenite-induced proliferation (Ouyang et al. 2007b). Although hyperproliferation is correlated with cellular transformation in some cases (Chen et al. 2001), our previous findings clearly demonstrated that in Cl41 cells, epidermal growth factor (EGF)-induced transformation was impaired by disrupting PI3K/p85 expression; however, cell proliferation was not affected (Huang et al. 1996), which indicates that the transformation ability is not always paralleled with the accelerated proliferation rate. Therefore, we performed the present studies to investigate whether the PI-3K/Akt signal pathway is indeed implicated in arsenite-induced cell transformation through the induction of cyclin D1.
###end p 14
###begin title 15
Materials and Methods
###end title 15
###begin title 16
Cell culture and reagents
###end title 16
###begin p 17
###xml 144 145 138 139 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 240 241 234 235 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 631 632 624 625 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 992 1009 981 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22-ehp0116-000001">Huang et al. 1996</xref>
###xml 1011 1025 1000 1014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27-ehp0116-000001">Li et al. 2004</xref>
###xml 1027 1045 1016 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34-ehp0116-000001">Ouyang et al. 2006</xref>
###xml 27 32 <span type="species:ncbi:9606">human</span>
###xml 215 221 <span type="species:ncbi:9913">bovine</span>
###xml 286 291 <span type="species:ncbi:9606">human</span>
###xml 427 432 <span type="species:ncbi:9606">human</span>
###xml 458 464 <span type="species:ncbi:9913">bovine</span>
Spontaneously immortalized human keratinocytes, HaCat cell line, and their stable transfectants were cultured in monolayers at 37degreesC, 5% CO2 using Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS), 2 mM l-glutamine, and 25 mug gentamicin/mL. Normal human epidermal keratinocytes (NHEKs) were cultured in keratinocyte-SFM medium (Invitrogen Corp., Carlsbad, CA, USA) containing supplements (human epidermal growth factor, bovine pituitary extract; Invitrogen) and gentamycin (5 mg/mL; Sigma-Aldrich Corp., St. Louis, MO, USA). The cultures were detached with trypsin and transferred to new 75-cm2 culture flasks (Fisher Scientific Co., Pittsburgh, PA, USA) twice a week. FBS was purchased from Life Technologies, Inc.; DMEM was from Calbiochem (San Diego, CA, USA); sodium arsenite was purchased from Aldrich Chemical Co. Inc. (Milwaukee, WI, USA). The dominant-negative mutants of Akt (DN-Akt) and PI-3K (Deltap85) were described in our previous studies (Huang et al. 1996; Li et al. 2004; Ouyang et al. 2006).
###end p 17
###begin title 18
Cyclin D1 small interference RNA construction
###end title 18
###begin p 19
###xml 91 110 91 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37-ehp0116-000001">Ouyang et al. 2005b</xref>
###xml 53 58 <span type="species:ncbi:9606">human</span>
The specific small interference RNA (siRNA)-targeted human cyclin D1 was described before (Ouyang et al. 2005b). The target sequence was inserted into the pSuppressor vector and verified by DNA sequencing.
###end p 19
###begin title 20
Stable transfection
###end title 20
###begin p 21
###xml 977 996 971 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37-ehp0116-000001">Ouyang et al. 2005b</xref>
We transfected HaCat cells with DN-Akt and Deltap85 or vector control plasmids using Lipofectamine 2000 reagent (Invitrogen Corp.) according to manufacturer's instructions. Briefly, HaCat cells were cultured in a 6-well plate to 85-90% confluence. Five micrograms plasmid DNA, alone or in combination with pCMV-neo vector, were for co-transfection. DNA was mixed with 10 muL of Lipofectamine 2000 reagent and used to transfect each well in the absence of serum. After 6-8 hr, the medium was replaced with 10% FBS DMEM. Approximately 30-36 hr after the beginning of the transfection, the cells were detached with 0.033% trypsin, and cell suspensions were plated into 75-mL culture flasks and cultured for 24-28 days with G418 selection (800 mug/mL). Stable transfectants were established and cultured in G418-free DMEM for at least two passages before each experiment. HaCat cells were stably transfected with siCyclin D1 as established and identified in our published studies (Ouyang et al. 2005b).
###end p 21
###begin title 22
PI-3 kinase assay
###end title 22
###begin p 23
###xml 82 99 82 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22-ehp0116-000001">Huang et al. 1996</xref>
###xml 101 119 101 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34-ehp0116-000001">Ouyang et al. 2006</xref>
###xml 270 271 270 271 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 641 642 633 634 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 981 982 966 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 1013 1014 998 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 1063 1064 1048 1049 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 1279 1280 1262 1263 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1282 1283 1265 1266 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1382 1383 1364 1365 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1444 1446 1420 1422 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1847 1848 1820 1821 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2022 2023 1989 1990 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
We conducted the PI-3 kinase activity assay as described in our previous reports (Huang et al. 1996; Ouyang et al. 2006). Briefly, cells were cultured in monolayers in 100-mm dishes using normal culture medium. The medium was replaced with 0.1% FBS DMEM containing 2 mM l-glutamine and 25 mug gentamicin/mL after the cell density reached 70-80%. Forty-five hours later, we incubated the cells with fresh serum-free DMEM for 3-4 hr at 37degreesC. Arsenite was then added to the cell cultures for PI-3K induction. The cells were washed once with ice-cold PBS and lysed in 400 muL lysis buffer/plate [20 mM Tris (pH 8.0), 137 mM NaCl, 1 mM MgCl2, 10% glycerol, 1% NP-40, 1-mM DTT, 0.4 mM sodium ortho-vanadate, and 1 mM phenylmethylsulfonyl fluoride]. The lysates were centrifuged and the supernatants were incubated at 4degreesC with 40 muL agarose beads (conjugated with the anti-phosphotyrosine antibody Py20) overnight. Beads were washed twice with each of the following buffers: a) PBS with 1% NP-40, 1 mM DTT; b) 0.1 M Tris (pH 7.6), 0.5 M LiCl, l mM DTT; and c) 10 mM Tris (pH 7.6), 0.1 M NaCl, 1 mM DTT. Beads were incubated for 5 min on ice in 20 muL buffer 3, then 20 muL of 0.5 mg/mL phosphatidylinositol [sonicated previously in 50 mM HEPES (pH 7.6), 1 mM EGTA, 1 mM NaH2PO4] were added. After 5 min at room temperature, 10 muL of the reaction buffer were added [50 mM MgCl2, 100 mM HEPES (pH 7.6), 250 muM ATP containing 5 muCi gamma-32P- ATP], and the beads were incubated for an additional 15 min. The reactions were stopped by the addition of 15 muL of 4 N HCl and 130 muL chloroform/methanol (1:1). After vortexing for 30 sec, the solutions, 30 muL from the phospholipid-containing chloroform phase were spotted onto thin-layer chromagraphy plates coated with silica gel H containing 1.3% potassium oxalate and 2 mM EDTA applied in H2O/methanol (3:2). The plates were heated at 110degreesC for at least 3 hr before use. The plates were then placed in tanks containing chloroform/methanol/ammonium hydroxide/H2O (600:470:20:113) for 40-50 min until the solvent reached the top of the plates. The plates were dried at room temperature and autoradiographed.
###end p 23
###begin title 24
Western blot analysis
###end title 24
###begin p 25
###xml 55 56 55 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 203 204 203 204 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 985 1003 978 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34-ehp0116-000001">Ouyang et al. 2006</xref>
###xml 807 813 <span type="species:ncbi:9986">rabbit</span>
We cultured HaCat cells and their transfectants (2 x 105) in each well of 6-well plates to 70-80% confluence with normal culture medium. The cell culture medium was replaced with 0.1% FBS DMEM with 2 mM l-glutamine and 25 mug gentamicin and cultured for 43 hr. The cells were incubated in serum-free DMEM for 3-4 hr at 37degreesC. After exposure to arsenite, the cells were washed once with ice-cold PBS, then extracted with sodium dodecyl sulfate (SDS)-sample buffer. The cell extracts were separated on polyacrylamide-SDS gels, transferred, and probed with each of the antibodies against phosphor-specific Akt (Thr308), phosphor-specific Akt (Ser473), Akt, cyclin D1, and glyceraldehyde 3-phosphate dehydrogenase. The protein bands specifically bound to the primary antibodies were detected using an anti-rabbit IgG alkaline phosphatase-linked secondary antibody and an ECF (enhanced chemifluorescence) Western blot analysis system (Amersham Pharmacia Biotech, Piscataway, NJ, USA) (Ouyang et al. 2006).
###end p 25
###begin title 26
Cell proliferation assay
###end title 26
###begin p 27
###xml 64 65 64 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 252 253 245 246 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Confluent monolayers of HaCat cells were trypsinized, and 1 x 103 of viable cells suspended in 100 muL DMEM supplemented with 10% FBS were added to each well of 96-well plates. The plates were incubated at 37degreesC in a humidified atmosphere of 5% CO2. Twelve hours later, we exposed the cells to arsenite for 5 days at the concentrations indicated. The exposed cells were lysed with 50 muL lysis buffer, and the proliferation of the cells was measured using CellTiter-Glo Luminescent Cell Viability Assay kit (Promega, Madison, WI, USA) with a luminometer (Wallac 1420 Victor2 multipliable counter system; Perkin-Elmer Life and Analytical Sciences, Inc., Waltham, MA, USA). The results are expressed as luciferase activity relative to control medium (proliferation index).
###end p 27
###begin title 28
Anchorage-independent growth
###end title 28
###begin p 29
###xml 55 56 55 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 397 414 396 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21-ehp0116-000001">Huang et al. 1999</xref>
###xml 416 431 415 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b55-ehp0116-000001">Yan et al. 2006</xref>
###xml 601 602 600 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 744 745 737 738 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
We cultured HaCat cells and their transfectants (1 x 105) in each well of 6-well plates to 50-60% confluence with normal culture medium. The cells were treated with 2.5 muM arsenite for 3 days, then recovered in fresh medium for 1 day. After the repeated treatment with arsenite for 8 weeks, the cells were used for anchorage-independent growth assay, which was performed as described previously (Huang et al. 1999; Yan et al. 2006). Briefly, 2.5 mL of 0.5% agar in basal modified Eagle's medium (BMEM) supplemented with 10% FBS was laid onto each well of 6-well tissue culture plates. We mixed 2 x 104 HaCat cells with 2 mL of 0.5% agar BMEM and layered the cells on top of the 0.5% agar layer. The plates were incubated at 37degreesC in 5% CO2 for 3 weeks. We then scored the colonies with more than 16 cells.
###end p 29
###begin title 30
Tumorigenicity assays
###end title 30
###begin p 31
###xml 186 187 186 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 270 271 269 270 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 496 516 495 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7-ehp0116-000001">Brubaker et al. 2006</xref>
###xml 518 539 517 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25-ehp0116-000001">Jungwirth et al. 1997</xref>
###xml 596 615 595 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33-ehp0116-000001">Ouyang et al. 2007a</xref>
###xml 42 51 <span type="species:ncbi:10090">nude mice</span>
###xml 140 145 <span type="species:ncbi:10090">mouse</span>
###xml 244 248 <span type="species:ncbi:10090">mice</span>
###xml 643 647 <span type="species:ncbi:10090">mice</span>
We randomly divided six 5-week-old female nude mice into two experimental groups-medium control group and arsenite-treated group. Each nude mouse was injected sc in two spots with 2 x 106 of cells in 100 muL of growth medium for each spot. The mice were sacrificed by CO2 asphyxiation 4 weeks after the inoculation, tumor dimensions were measured using calipers and tumor volume (cubic millimeters) was calculated using the following formula: 0.5236 (L x W x H) as described in previous studies (Brubaker et al. 2006; Jungwirth et al. 1997), where L is tumor length, W is width, and H is height (Ouyang et al. 2007a). Tumors were removed from mice, and fixed in 10% buffered formalin and embedded in paraffin; 5-mum sections were dehydrated and stained with hematoxylin and eosin (H&E).
###end p 31
###begin title 32
Statistical analysis
###end title 32
###begin p 33
###xml 100 101 100 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
The significant difference between the treated and untreated groups was determined with the Student t-test. Results are expressed as mean +/- SD.
###end p 33
###begin title 34
Results
###end title 34
###begin title 35
Repeated arsenite exposure led to transformation of HaCat cells
###end title 35
###begin p 36
###xml 156 164 156 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 398 407 397 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1-ehp0116-000001">Figure 1A</xref>
###xml 487 496 485 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1-ehp0116-000001">Figure 1A</xref>
###xml 930 942 926 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1-ehp0116-000001">Figure 1B, C</xref>
###xml 1186 1195 1182 1191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1-ehp0116-000001">Figure 1D</xref>
###xml 1327 1328 1321 1322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1396 1397 1388 1389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1496 1505 1488 1497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1-ehp0116-000001">Figure 1E</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 125 130 <span type="species:ncbi:9606">human</span>
###xml 539 544 <span type="species:ncbi:9606">human</span>
###xml 1163 1172 <span type="species:ncbi:10090">nude mice</span>
###xml 1259 1264 <span type="species:ncbi:10090">mouse</span>
Human skin is a major target of environmental carcinogen arsenite. To elucidate the mechanism implicated in arsenite-induced human skin carcinogenic effect in vitro, we first evaluated the cytotoxicity of arsenite to HaCat cells with CellTiter-Glo Luminescent Cell Viability Assay kit. We found that exposure of HaCat cell to 0.625 muM arsenite caused a significant increase in cell proliferation (Figure 1A) and no inhibition of cell proliferation at doses lower than 2.5 muM arsenite (Figure 1A). Thus, we used 2.5 muM arsenite to treat human keratinocyte HaCat cells to establish a cell transformation model. HaCat cells were exposed repeatedly to 2.5 muM arsenite twice a week for 8 weeks, and the anchorage-independent growth capability of arsenite-treated HaCat cells was evaluated. Compared with the medium control, repeated arsenite exposure resulted in increased the anchorage-independent growth capacity of HaCat cells (Figure 1B, C). Those results indicate that arsenite-exposed HaCat cells obtain the ability of anchorage-independent growth for colony formation in soft agar. The tumor characteristic of the transformed cells was further confirmed in nude mice. As shown in Figure 1D, injection of arsenite long-term exposed Hacat cells into nude mouse caused observable tumor formation (tumor volumes 786 +/- 126, n = 6) compared with that of long-term culture HaCat cells (0 +/- 0, n = 6). H&E staining also revealed a tumor formation in the arsenite long-term exposed Hacat cells (Figure 1E). On the basis of these results, we anticipate that repeated exposure of HaCat cells to arsenite could cause malignant transformation.
###end p 36
###begin title 37
The PI-3K/Akt pathway is required for arsenite-induced transformation of HaCat cells
###end title 37
###begin p 38
###xml 130 131 130 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 185 202 185 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21-ehp0116-000001">Huang et al. 1999</xref>
###xml 204 223 204 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37-ehp0116-000001">Ouyang et al. 2005b</xref>
###xml 352 370 352 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34-ehp0116-000001">Ouyang et al. 2006</xref>
###xml 667 679 667 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2-ehp0116-000001">Figure 2A, B</xref>
###xml 731 743 731 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2-ehp0116-000001">Figure 2C, D</xref>
###xml 324 329 <span type="species:ncbi:10090">mouse</span>
###xml 810 815 <span type="species:ncbi:9606">human</span>
Our previous studies have shown that PI-3K is essential for Cl41 cells obtaining anchorage-independent growth capacity in TPA (12-O-tetradecanoylphorbol-13-acetate) and EGF treatments (Huang et al. 1999; Ouyang et al. 2005b). In addition, our published studies have shown that arsenite exposure is able to activate PI-3K in mouse epidermal Cl41 cells (Ouyang et al. 2006). To determine the potential involvement of the PI-3K pathway in arsenite-induced HaCat cell transformation, we tested the PI-3K activity in arsenite-exposed HaCat cells. The results showed that the arsenite exposure did increase PI-3K activation in HaCat cells compared with the medium control (Figure 2A, B). We also further confirmed this finding in NHEKs (Figure 2C, D). The aforementioned data demonstrate that PI-3K is implicated in human keratinocyte response to arsenite exposure.
###end p 38
###begin p 39
###xml 258 276 258 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1-ehp0116-000001">Alessi et al. 1997</xref>
###xml 278 300 278 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b49-ehp0116-000001">Toker and Cantley 1997</xref>
###xml 475 493 475 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1-ehp0116-000001">Alessi et al. 1997</xref>
###xml 495 513 495 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14-ehp0116-000001">Franke et al. 2003</xref>
###xml 778 790 778 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3-ehp0116-000001">Figure 3A, B</xref>
###xml 1101 1110 1093 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3-ehp0116-000001">Figure 3A</xref>
###xml 1205 1217 1197 1209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3-ehp0116-000001">Figure 3C, D</xref>
###xml 563 568 <span type="species:ncbi:9606">human</span>
###xml 888 893 <span type="species:ncbi:9606">human</span>
Upon activation, PI-3K generates phosphatidylinositol-3,4,5-trisphosphate (PIP3), a lipid second messenger essential for the translocation of Akt to the plasma membrane where it is phosphorylated and activated by phosphoinositide-dependent kinase-1 (PDK-1) (Alessi et al. 1997; Toker and Cantley 1997). Subsequently, Akt phosphorylates and regulates the function of many downstream cellular proteins involved in the processes of apoptosis, proliferation, and transformation (Alessi et al. 1997; Franke et al. 2003). To test possible Akt activation by arsenite in human keratinocytes, we determined Akt activation in both HaCat and NHEKs by evaluating its phosphorylation at Thr308 and Ser473. The results indicated that arsenite exposure was able to activate Akt in both cells (Figure 3A, B), which was consistent with PI-3K activation. To elucidate the PI-3K/Akt pathway and its role in human keratinocyte response to arsenite response, we established the stable HaCat Deltap85 and DN-Akt transfectants. Ectopic expression of Deltap85 and DN-Akt dramatically reduced arsenite-induced Akt activation (Figure 3A), and consequently blocked cell transformation upon chronic arsenite exposure in HaCat cells (Figure 3C, D). These results demonstrate the critical role of the PI-3K/Akt pathway in arsenite-induced HaCat transformation.
###end p 39
###begin title 40
Cyclin D1 is a key PI-3K/Akt downstream protein responsible for arsenite-induced transformation of HaCat cells
###end title 40
###begin p 41
###xml 350 369 350 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37-ehp0116-000001">Ouyang et al. 2005b</xref>
###xml 613 622 613 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4-ehp0116-000001">Figure 4A</xref>
###xml 635 644 635 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4-ehp0116-000001">Figure 4B</xref>
###xml 746 755 742 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4-ehp0116-000001">Figure 4C</xref>
###xml 1036 1045 1028 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3-ehp0116-000001">Figure 3A</xref>
###xml 2355 2364 2339 2348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3-ehp0116-000001">Figure 3A</xref>
It has been thought that the contribution of the PI-3K/Akt pathway to tumorigenesis could be associated with either its regulation of cell apoptosis or cell growth. Our previous studies have shown that arsenite exposure is able to up-regulate cyclin D1 protein expression in HaCat cells, which further mediates cell cycle alternation in HaCat cells (Ouyang et al. 2005b). Thus, it is important to determine whether there is a link between arsenite-induced PI-3K/Akt activation and cyclin D1 protein expression. Arsenite treatment resulted in a marked increase in cyclin D1 protein expression in both HaCat cells (Figure 4A) and NHEKs (Figure 4B), and this cyclin D1 induction was dramatically impaired in Deltap85 or DN-Akt stable transfectants (Figure 4C), indicating that the PI-3K/Akt pathway is critical for cyclin D1 protein induction by arsenite. It might be noted that overexpression of DN-Akt was able to block Akt activation, whereas Deltap85 only showed a partial inhibition of Akt activation induced upon arsenite treatment (Figure 3A). This differential inhibition of Akt phosphorylation by DN-Akt and Deltap85 could be due to the protein expression levels of those two exogenous dominant negative mutants, or alternate pathways may be involved in the Akt activation. It might also be noted that Deltap85 is able to block arsenite-induced cyclin D1 expression completely, whereas it shows only partial inhibition on Akt phosphorylation. The explanation for this may be that Akt is only one of p85 downstream kinases, and the other p85 downstream kinases such as protein kinase C, serum gluco-corticoid-inducible kinase, and Rac/CDC42 may also play some role in cyclin D1 protein expression in arsenite responses. In addition, cyclin D1 induction might need PI-3K activation to a certain level, so when Akt activation was relatively low, it was not able to cause cyclin D1 induction. The basal level of Akt phosphorylation in DN-Akt transfectants was higher than that of the vector control (Mock) transfectants. The explanation was that, due to the importance of Akt in normal cell function, the phosphorylation of the endogenous Akt in DN-Akt stable transfectant was elevated to overcome the biological effects caused by over-expression of exogenous DN-Akt. However, the arsenite-induced phosphorylation will be greatly inhibited, as shown in Figure 3A.
###end p 41
###begin p 42
###xml 169 188 169 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37-ehp0116-000001">Ouyang et al. 2005b</xref>
###xml 203 212 203 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4-ehp0116-000001">Figure 4D</xref>
###xml 553 565 553 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4-ehp0116-000001">Figure 4D, E</xref>
###xml 780 785 <span type="species:ncbi:9606">human</span>
To evaluate the contribution of cyclin D1 protein expression to arsenite-induced HaCat cell transformation, we used HaCat cells stably transfected with cyclin D1 siRNA (Ouyang et al. 2005b). As shown in Figure 4D, introduction of cyclin D1 siRNA dramatically reduced the basal level of the cyclin D1 protein expression, whereas it did not affect the basal level of the cyclin D2 protein expression, verifying the specificity of cyclin D1 siRNA. Knockdown of cyclin D1 expression by its siRNA abrogated the HaCat cell transformation induced by arsenite (Figure 4D, E). Collectively, these results indicate that cyclin D1 is not only induced by arsenite exposure through the PI-3K/Akt-dependent pathway but it is also at least one of the key events responsible for arsenite-induced human keratinocyte transformation.
###end p 42
###begin title 43
Discussion
###end title 43
###begin p 44
###xml 84 103 84 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9-ehp0116-000001">Centeno et al. 2002</xref>
###xml 105 122 105 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19-ehp0116-000001">Huang et al. 2004</xref>
###xml 124 141 124 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b50-ehp0116-000001">Tseng et al. 1968</xref>
###xml 143 157 143 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b56-ehp0116-000001">Yu et al. 2006</xref>
###xml 393 417 393 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6-ehp0116-000001">Bernstam and Nriagu 2000</xref>
###xml 803 822 803 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36-ehp0116-000001">Ouyang et al. 2007b</xref>
###xml 27 32 <span type="species:ncbi:9606">human</span>
###xml 484 489 <span type="species:ncbi:9606">human</span>
Arsenite is a well-defined human carcinogen, with skin as its primary target organ (Centeno et al. 2002; Huang et al. 2004; Tseng et al. 1968; Yu et al. 2006). Because arsenite has only a weak mutagenic effect, it is thought that its ability to activate some signaling pathways and gene expression responsible for cell growth may play an important role in mediating its carcinogenetic effect (Bernstam and Nriagu 2000). In the present study, we demonstrated that repeated exposure of human keratinocytes to low doses of arsenite resulted in cell transformation with the characteristic of cell anchorage-independent growth in soft agar. The dose we used to repeatedly treat cells did not cause obvious cell death. On the contrary, it promoted cell proliferation as we reported in our recent publication (Ouyang et al. 2007b). The treatment of cells with arsenite also caused the activation of PI-3K/Akt, which thereby plays a critical role in arsenite-induced cell transformation through induction of cyclin D1 expression.
###end p 44
###begin p 45
###xml 130 157 130 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32-ehp0116-000001">Nicholson and Anderson 2002</xref>
###xml 159 183 159 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b43-ehp0116-000001">Samuels and Ericson 2006</xref>
###xml 307 331 307 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b43-ehp0116-000001">Samuels and Ericson 2006</xref>
###xml 430 449 430 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23-ehp0116-000001">Jimenez et al. 1998</xref>
###xml 451 468 451 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40-ehp0116-000001">Philp et al. 2001</xref>
###xml 579 606 579 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32-ehp0116-000001">Nicholson and Anderson 2002</xref>
###xml 844 868 844 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b43-ehp0116-000001">Samuels and Ericson 2006</xref>
###xml 565 570 <span type="species:ncbi:9606">human</span>
###xml 1072 1077 <span type="species:ncbi:9606">human</span>
###xml 1169 1174 <span type="species:ncbi:9606">human</span>
As an important signal pathway for cell survival and growth, PI-3K/Akt has been demonstrated to be associated with tumorigenesis (Nicholson and Anderson 2002; Samuels and Ericson 2006). More than 30% of various solid tumor were found recently to contain mutations in PIK3CA, the catalytic subunit of PI-3K (Samuels and Ericson 2006). The mutation in p85, a regulatory subunit of PI-3K, has also been reported in previous studies (Jimenez et al. 1998; Philp et al. 2001). Recent studies also indicate that Akt is frequently constitutively activated in many types of human cancer (Nicholson and Anderson 2002). Although the mechanisms have not yet been fully characterized, constitutive PI-3K/Akt signaling is believed to promote proliferation and increase cell survival, which is an indispensable event during the process of cancer development (Samuels and Ericson 2006). Current studies demonstrated that arsenite exposure was able to activate PI-3K and Akt, and inhibition of either PI-3K or Akt by their dominant mutants impaired arsenite-induced cell transformation in human skin keratinocytes HaCat, suggesting that the PI-3K/Akt pathway may contribute to arsenite human skin carcinogenic effects.
###end p 45
###begin p 46
###xml 116 136 116 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b48-ehp0116-000001">Sullivan et al. 1994</xref>
###xml 236 255 236 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13-ehp0116-000001">Duyndam et al. 2001</xref>
###xml 257 274 257 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38-ehp0116-000001">Ozaki et al. 2000</xref>
###xml 356 374 356 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24-ehp0116-000001">Jung et al. (2003)</xref>
###xml 477 478 477 478 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 479 480 479 480 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 673 674 673 674 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 675 676 675 676 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 694 695 694 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 737 738 737 738 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 739 740 739 740 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 803 819 803 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24-ehp0116-000001">Jung et al. 2003</xref>
Reactive oxygen species (ROS) at low concentration may function as a signaling intermediator of cellular responses (Sullivan et al. 1994). The production of ROS in response to arsenite treatment has been observed in various cell lines (Duyndam et al. 2001; Ozaki et al. 2000), suggesting that arsenite may act early in the growth factor signaling pathway. Jung et al. (2003) have clearly demonstrated that the predominant product by arsenite appeared to be hydrogen peroxide (H2O2) because the arsenite-induced increase in dichlorofluorescein (DCF) fluorescence was completely abolished by pretreatment with catalase but not with heat-inactivated catalase. By eliminating H2O2 with catalase or N-acetylcysteine, they further found that H2O2 might act as an upstream molecule of PI-3K as well as ERK1/2 (Jung et al. 2003). So we propose that the generation of ROS by arsenite may be associated with various cellular processes, such as PI-3K/Akt pathway activation.
###end p 46
###begin p 47
###xml 101 117 101 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11-ehp0116-000001">Cook et al. 2000</xref>
###xml 119 136 119 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39-ehp0116-000001">Perry et al. 1998</xref>
###xml 138 162 138 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b53-ehp0116-000001">Winston and Pledger 1993</xref>
###xml 238 261 238 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5-ehp0116-000001">Barnes and Gillett 1998</xref>
###xml 263 287 263 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15-ehp0116-000001">Fusenig and Boukamp 1998</xref>
###xml 289 303 289 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b52-ehp0116-000001">Weinstein 2000</xref>
###xml 403 422 403 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31-ehp0116-000001">Nichols et al. 1996</xref>
###xml 432 451 432 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b54-ehp0116-000001">Worsley et al. 1997</xref>
###xml 462 484 462 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29-ehp0116-000001">Michalides et al. 1996</xref>
###xml 504 523 504 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b41-ehp0116-000001">Proctor et al. 1991</xref>
###xml 539 565 539 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b45-ehp0116-000001">Semczuk and Jakowicki 2004</xref>
###xml 578 606 578 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b42-ehp0116-000001">Rodriguez-Puebla et al. 1999</xref>
###xml 769 786 769 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2-ehp0116-000001">Arber et al. 1997</xref>
###xml 788 806 788 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b44-ehp0116-000001">Sauter et al. 1999</xref>
###xml 943 971 943 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b42-ehp0116-000001">Rodriguez-Puebla et al. 1999</xref>
###xml 973 989 973 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b46-ehp0116-000001">Shen et al. 2006</xref>
###xml 362 367 <span type="species:ncbi:9606">human</span>
###xml 693 698 <span type="species:ncbi:9606">human</span>
###xml 742 747 <span type="species:ncbi:9606">human</span>
###xml 1106 1111 <span type="species:ncbi:10090">mouse</span>
###xml 1323 1328 <span type="species:ncbi:9606">human</span>
Cyclin D1 could be induced by growth factors and stress, then regulate cell cycle and proliferation (Cook et al. 2000; Perry et al. 1998; Winston and Pledger 1993). Aberrant cyclin D1 expression has been observed early in carcinogenesis (Barnes and Gillett 1998; Fusenig and Boukamp 1998; Weinstein 2000), and overexpression of cyclin D1 was reported in several human cancers, including uterine cervix (Nichols et al. 1996), ovary (Worsley et al. 1997), breast (Michalides et al. 1996), urinary bladder (Proctor et al. 1991), endometrium (Semczuk and Jakowicki 2004), and skin (Rodriguez-Puebla et al. 1999). Antisense to cyclin D1 was reported to inhibit the growth and the tumorigenicity of human colon cancer cells and induce apoptosis in human squamous carcinomas (Arber et al. 1997; Sauter et al. 1999). It has been demonstrated that carcinogenic compounds can induce cyclin D1 expression, which in turn promote tumor cell proliferation (Rodriguez-Puebla et al. 1999; Shen et al. 2006). Our previous studies showed that arsenite could activate the PI-3K/Akt pathway and induce cyclin D1 expression in mouse epidermal cells. In this study, we provided the first direct evidence that cyclin D1 is a downstream target of the PI-3K/Akt signal cascade and involved in the cell transformation caused by arsenite exposure in human keratinocytes.
###end p 47
###begin p 48
###xml 225 237 225 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3-ehp0116-000001">Figure 3D, F</xref>
###xml 638 653 634 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16-ehp0116-000001">Gao et al. 2004</xref>
###xml 854 873 850 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26-ehp0116-000001">Larcher et al. 1998</xref>
###xml 98 103 <span type="species:ncbi:9606">human</span>
Although knockdown of cyclin D1 expression by its siRNA markedly inhibited cell transformation of human keratinocytes exposed to arsenite, its effect was less than expression of the dominant negative mutants of PI-3K or Akt (Figure 3D, F). It was likely that some other downstream molecules might also be the PI-3K/Akt downstream targets partially responsible for arsenite-induced cell transformation. For example, in addition to cyclin D1 induction, the PI-3K/Akt pathway has also been reported to mediate the up-regulation of hypoxia-inducible factor 1alpha and its downstream target gene vascular endothelial growth factor expression (Gao et al. 2004), which has been reported to promote cell transformation, induce the anti-apoptosis genes expression, and subsequently render the cell apoptosis resistance, and promote cell immigration and invasion (Larcher et al. 1998).
###end p 48
###begin p 49
###xml 118 123 <span type="species:ncbi:9606">human</span>
###xml 334 339 <span type="species:ncbi:9606">human</span>
In summary, our studies demonstrate that the PI-3K/Akt pathway plays a role in the arsenite-induced transformation of human keratinocytes through the induction of cyclin D1. These results provide novel information for understanding the molecular mechanisms underlying the carcinogenic effect of arsenite on its major target tissue of human skin, which also suggests that the PI-3K/Akt/cyclin D1 pathway might be a target for chemo-prevention of arsenite-induced skin cancer.
###end p 49
###begin p 50
This work was supported in part by grants from the National Institutes of Health (NIH)/National Cancer Institute R01 CA094964 (C.H.), R01 CA112557 (C.H.), R01 CA103180 (C.H.), R01 CA119028 (X.S.), NIH/National Institute of Environmental Health Sciences (NIEHS) R01 ES012451 (C.H.), and NIEHS Center grant ES000260.
###end p 50
###begin title 51
References
###end title 51
###begin article-title 52
###xml 98 108 <span type="species:ncbi:7227">Drosophila</span>
3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase
###end article-title 52
###begin article-title 53
###xml 65 70 <span type="species:ncbi:9606">human</span>
Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells
###end article-title 53
###begin article-title 54
###xml 52 57 <span type="species:ncbi:9606">human</span>
Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells
###end article-title 54
###begin article-title 55
Bcl-w promotes gastric cancer cell invasion by inducing matrix metalloproteinase-2 expression via phosphoinositide 3-kinase, Akt, and Sp1
###end article-title 55
###begin article-title 56
Cyclin D1 in breast cancer
###end article-title 56
###begin article-title 57
Molecular aspects of arsenic stress
###end article-title 57
###begin article-title 58
Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment
###end article-title 58
###begin article-title 59
The phosphoinositide 3-kinase pathway
###end article-title 59
###begin article-title 60
Pathology related to chronic arsenic exposure
###end article-title 60
###begin article-title 61
Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation
###end article-title 61
###begin article-title 62
Regulation of cell cycle re-entry by growth, survival and stress signalling pathways
###end article-title 62
###begin article-title 63
Roles of mitogen activated protein kinases and EGF receptor in arsenite-stimulated matrix metalloproteinase-9 production
###end article-title 63
###begin article-title 64
Induction of vascular endothelial growth factor expression and hypoxia-inducible factor 1alpha protein by the oxidative stressor arsenite
###end article-title 64
###begin article-title 65
PI3K/Akt and apoptosis: size matters
###end article-title 65
###begin article-title 66
###xml 111 116 <span type="species:ncbi:9606">human</span>
Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes
###end article-title 66
###begin article-title 67
###xml 92 97 <span type="species:ncbi:9606">human</span>
Arsenite induces HIF-1alpha and VEGF through PI3K, Akt and reactive oxygen species in DU145 human prostate carcinoma cells
###end article-title 67
###begin article-title 68
###xml 27 32 <span type="species:ncbi:9606">human</span>
Chronic UVA irradiation of human HaCaT keratinocytes induces malignant transformation associated with acquired apoptotic resistance
###end article-title 68
###begin article-title 69
###xml 30 35 <span type="species:ncbi:10090">mouse</span>
Three stage carcinogenesis in mouse skin-recent results and present status of an advanced model system of chemical carcinogenesis
###end article-title 69
###begin article-title 70
Molecular mechanisms of arsenic carcinogenesis
###end article-title 70
###begin article-title 71
###xml 85 90 <span type="species:ncbi:10090">mouse</span>
Arsenic-induced NFkappaB transactivation through Erks-and JNKs-dependent pathways in mouse epidermal JB6 cells
###end article-title 71
###begin article-title 72
###xml 108 109 108 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
JNK Activation is required for JB6 cell transformation induced by tumor necrosis factor-alpha but not by 12-O-tetradecanoylphorbol-13-acetate
###end article-title 72
###begin article-title 73
###xml 129 130 129 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Requirement for phosphatidylinositol 3-kinase in epidermal growth factor-induced AP-1 transactivation and transformation in JB6 P+ cells
###end article-title 73
###begin article-title 74
Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3-kinase
###end article-title 74
###begin article-title 75
Hydrogen peroxide mediates arsenite activation of p70s6k and extracellular signal-regulated kinase
###end article-title 75
###begin article-title 76
Growth hormone-releasing hormone antagonist MZ-4-71 inhibits in vivo proliferation of Caki-I renal adenocarcinoma
###end article-title 76
###begin article-title 77
###xml 35 50 <span type="species:ncbi:10090">transgenic mice</span>
VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development
###end article-title 77
###begin article-title 78
###xml 115 120 <span type="species:ncbi:10090">mouse</span>
A critical role of PI-3K/Akt/JNKs pathways in benzo[a]pyrene diolepoxide (B[a]PDE)-induced AP-1 transactivaiton in mouse epidermal Cl41 cells
###end article-title 78
###begin article-title 79
###xml 90 95 <span type="species:ncbi:10090">mouse</span>
ERKs activation and calcium signaling are both required for VEGF induction by vanadium in mouse epidermal Cl41 cells
###end article-title 79
###begin article-title 80
###xml 89 97 <span type="species:ncbi:9606">patients</span>
A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer
###end article-title 80
###begin article-title 81
Activation and crosstalk between Akt, NF-{kappa}B, and unfolded protein response signaling in 1-LN prostate cancer cells consequent to ligation of cell surface-associated GRP78
###end article-title 81
###begin article-title 82
###xml 29 34 <span type="species:ncbi:9606">human</span>
Cyclin D1 gene expression in human cervical neoplasia
###end article-title 82
###begin article-title 83
###xml 47 52 <span type="species:ncbi:9606">human</span>
The protein kinase B/Akt signalling pathway in human malignancy
###end article-title 83
###begin article-title 84
###xml 165 170 <span type="species:ncbi:10090">mouse</span>
Direct evidence for the critical role of NFAT3 in benzo[a]pyrene diolepoxide-induced cell transformation through mediation of inflammatory cytokine TNF induction in mouse epidermal Cl41 cells
###end article-title 84
###begin article-title 85
Essential roles of PI-3K/Akt/IKK{beta}/NF{kappa}B pathway in cyclin D1 induction by arsenite in JB6 Cl41 cells
###end article-title 85
###begin article-title 86
Essential role of PI-3K, ERKs and calcium signal pathways in nickel-induced VEGF expression
###end article-title 86
###begin article-title 87
###xml 88 93 <span type="species:ncbi:9606">human</span>
PI-3K/Akt signal pathway plays a crucial role in arsenite-induced cell proliferation of human keratinocytes through induction of cyclin D1
###end article-title 87
###begin article-title 88
###xml 166 171 <span type="species:ncbi:9606">human</span>
Cyclin D1 Induction through I{kappa}B kinase {beta}/nuclear factor-{kappa}B pathway is responsible for arsenite-induced increased cell cycle G1-S phase transition in human keratinocytes
###end article-title 88
###begin article-title 89
Rac1 Regulates stress-induced, redox-dependent heat shock factor activation
###end article-title 89
###begin article-title 90
###xml 47 52 <span type="species:ncbi:9606">human</span>
Epidermal growth factor induces cyclin D1 in a human prostate cancer cell line
###end article-title 90
###begin article-title 91
###xml 69 74 <span type="species:ncbi:9606">human</span>
The phosphatidylinositol 3'-kinase p85{alpha} gene is an oncogene in human ovarian and colon tumors
###end article-title 91
###begin article-title 92
Amplification at chromosome 11q13 in transitional cell tumours of the bladder
###end article-title 92
###begin article-title 93
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
ras activity and cyclin D1 expression: an essential mechanism of mouse skin tumor development
###end article-title 93
###begin article-title 94
Oncogenic PI3K and its role in cancer
###end article-title 94
###begin article-title 95
###xml 61 66 <span type="species:ncbi:9606">human</span>
Antisense cyclin D1 induces apoptosis and tumor shrinkage in human squamous carcinomas
###end article-title 95
###begin article-title 96
Alterations of pRb1-cyclin D1-cdk4/6-p16(INK4A) pathway in endometrial carcinogenesis
###end article-title 96
###begin article-title 97
Overexpression of cyclin D1-CDK4 in silica-induced transformed cells is due to activation of ERKs, JNKs/AP-1 pathway
###end article-title 97
###begin article-title 98
###xml 85 90 <span type="species:ncbi:9606">human</span>
Arsenite activation of P13K/AKT cell survival pathway is mediated by p38 in cultured human keratinocytes
###end article-title 98
###begin article-title 99
###xml 12 13 12 13 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 14 15 14 15 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Effects of H2O2 on protein tyrosine phosphatase activity in HER14 cells
###end article-title 99
###begin article-title 100
Signalling through the lipid products of phosphoinositide-3-OH kinase
###end article-title 100
###begin article-title 101
Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan
###end article-title 101
###begin article-title 102
###xml 49 54 <span type="species:ncbi:9606">human</span>
The phosphatidylinositol 3-Kinase AKT pathway in human cancer
###end article-title 102
###begin article-title 103
Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis
###end article-title 103
###begin article-title 104
Growth factor regulation of cyclin D1 mRNA expression through protein synthesis-dependent and -independent mechanisms
###end article-title 104
###begin article-title 105
Overexpression of cyclin D1 in epithelial ovarian cancers
###end article-title 105
###begin article-title 106
NFAT3 is specifically required for TNF-{alpha}-induced cyclooxygenase-2 (COX-2) expression and transformation of Cl41 cells
###end article-title 106
###begin article-title 107
Arsenic carcinogenesis in the skin
###end article-title 107
###begin article-title 108
###xml 95 100 <span type="species:ncbi:10090">mouse</span>
Alterations in signal transduction pathways implicated in tumour progression during multistage mouse skin carcinogenesis
###end article-title 108
###begin p 109
###xml 75 76 75 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 266 267 266 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 268 269 268 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 410 411 409 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 419 420 418 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 604 605 603 604 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 689 690 688 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 48 53 <span type="species:ncbi:9606">human</span>
###xml 489 498 <span type="species:ncbi:10090">nude mice</span>
###xml 667 671 <span type="species:ncbi:10090">mice</span>
Induction of cell transformation by arsenite in human keratinocyte HaCat. (A) HaCat cells were exposed to various doses of arsenite for 5 days. The proliferation of the cells was measured using CellTiter-Glo Luminescent Cell Viability Assay kit with a luminometer. (B,C) HaCat cells were then repeatedly exposed to 2.5 muM arsenite twice a week for a total of 8 weeks as described in "Materials and Methods." (D) 2 x 106 of above cells were injected sc into each spot of 5-week-old female nude mice. Four weeks after the inoculation, the tumor dimensions were measured using calipers and tumor volume (mm3) was calculated. The data shown are from six tumors in three mice for each group. (E) Paraffin-embedded tumor xenografts were sectioned (4 mum) and subjected to H&E staining.
###end p 109
###begin p 110
###xml 60 61 60 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
*Significant increase compared with that of medium control (p < 0.05).
###end p 110
###begin p 111
###xml 63 64 63 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 65 66 65 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 298 299 297 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 384 385 383 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 488 489 487 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 574 575 573 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 378 381 <span type="species:ncbi:59837">CPM</span>
###xml 457 462 <span type="species:ncbi:9606">human</span>
###xml 568 571 <span type="species:ncbi:59837">CPM</span>
PI-3K activation induced by arsenite in both HaCat and NHEKs. (A,B) HaCat cells with 70-80% confluence were exposed to 2.5 muM arsenite for 30 min, and the cells were harvested. The PI-3K activity was determined as described in "Materials and Methods." The results were shown as an autoradiograph (A) and schematic diagram of the PI-3K product PI(3)P from the PI-3K assay spot (CPM) (B). PI-3K activity by arsenite was determined in primary cultured normal human epidermal keratinocytes (C) and schematic diagram of the PI-3K product PI(3)P from the PI-3K assay spot (CPM) (D). The data shown represent one of three independent experiments.
###end p 111
###begin p 112
###xml 103 104 103 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 389 390 385 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 529 532 524 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C,D</italic>
Requirement of the PI-3K/Akt pathway activation for HaCat cell transformation upon arsenite exposure. (A) HaCat cells stable transfected with dominant negative mutants of Akt (DN-Akt) or p85 (Deltap85) or vector control (Mock) were treated with arsenite in different doses as indicated for 180 min. The number was the relative blots density of phosphorylated Akt compared with total Akt. (B) NHEKs were treated with 2.5 muM arsenite at different time points and the phosphorylation of Akt was detected with specific antibodies. (C,D) The anchorage-independent growth was evaluated among the HaCat cells stable transfected with vector control, DN-Akt, and Deltap85 after repeated exposure to arsenite for 8 weeks. Each bar indicates the mean and SE of triplicate assay wells.
###end p 112
###begin p 113
###xml 90 91 90 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
*Significant decrease compared with that from HaCat cells transfected with vector (Mock) (p < 0.05).
###end p 113
###begin p 114
###xml 84 85 84 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 98 99 98 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 165 166 164 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 182 183 181 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 302 303 301 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 510 511 505 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 659 660 654 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 661 662 656 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
A key role of cyclin D1 in arsenite-induced HaCat cell transformation. HaCat cells (A) and NHEKs (B) were treated with 5 muM arsenite for the indicated time period (A) or for 24 hr (B), and the cells were extracted with sample lysis buffer for Western blot analysis to determine cyclin D1 expression. (C) HaCat cells stable transfected with vector, DN-Akt, or Deltap85, were treated with arsenite at concentrations indicated, and cyclin D1 protein expression levels were evaluated with Western blot analysis. (D) Specific knockdown of cylin D1 in HaCat cells was identified with Western blot analysis compared with normal expression of cyclin D2 expression. (E,F) The capability of anchorage-independent growth activities was compared between cyclin D1 siRNA transfectant and nonspecific control siRNA transfectant after repeatedly treated with arsenite for 8 weeks. Each bar indicates the mean and SE of triplicate assay wells.
###end p 114
###begin p 115
*Significant decrease compared with that from HaCat cells transfected with control siRNA (Scramble).
###end p 115

